Skip to main content
Top

Drugs

Issue 17/2022

Content (7 Articles)

Treating Biliary Tract Cancers: New Targets and Therapies

  • Leading Article

Joseph Ho, Constance Fiocco, Kristen Spencer

Teprotumumab: A Review in Thyroid Eye Disease

Tina Nie, Yvette N. Lamb

Deucravacitinib: First Approval

Sheridan M. Hoy

Spesolimab: First Approval

Hannah A. Blair

Correction to: Valemetostat Tosilate: First Approval

  • Open Access
  • Correction

Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images